Analystreport

Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $45.00 to $40.00. They now have

Pacific Biosciences of California, Inc.  (PACB) 
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.pacificbiosciences.com